Insider filing · DNTH
Adam M Veness
SVP, General Counsel and Sec.
profile →
Dianthus Therapeutics, Inc.
DNTH · Healthcare · 18 filings in 24 months
ticker →
Adam M Veness sold $2.4M of Dianthus Therapeutics (DNTH)
Executed Jun 17, disclosed Jun 18, 1 day later.
Value, as filed
$2.4M
30,000 sh across 2 lots
Executed
Jun 17
the trade date, as filed
Disclosed
Jun 18
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
AVAdam M Veness (SVP, General Counsel and Sec.) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Dianthus Therapeutics, Inc. (DNTH). The largest single filing was $2.4M of DNTH (30,000 sh across 2 lots, as filed), executed Jun 17.
The name
DNTHHealthcare · Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoi…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Adam M Veness in DNTH
DNTHSALE
Dianthus Therapeutics, Inc.
$2.1M19,384 sh across 2 lots
Exec Aug 7
Filed Aug 11 · 5:08 PM ET